Medical and Pharmaceutical Kairos Pharma acquires lung cancer drug assets from Celyn Therapeutics Shares surged by 16% after the deal was announced Rowan DunneMarch 2, 2026
Medical and Pharmaceutical Kairos Pharma gets US$876K DoD grant for lung cancer treatment resistance research The company has developed an antibody to fight against a protein that makes lung cancer cells resistant to drugs Rowan DunneApril 17, 2025